# The Effect of Guanfacine on Delirium in Critically Ill Patients

> **NCT04578886** · PHASE3 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 100 (actual)

## Conditions studied

- Delirium

## Interventions

- **DRUG:** Guanfacine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04578886
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-23
- **Primary completion:** 2023-02-20
- **Final completion:** 2023-04-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04578886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04578886, "The Effect of Guanfacine on Delirium in Critically Ill Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04578886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*